Literature DB >> 23283952

Identification of the N-terminal domain of the influenza virus PA responsible for the suppression of host protein synthesis.

Emily A Desmet1, Kendra A Bussey, Raychel Stone, Toru Takimoto.   

Abstract

Cellular protein synthesis is suppressed during influenza virus infection, allowing for preferential production of viral proteins. To explore the impact of polymerase subunits on protein synthesis, we coexpressed enhanced green fluorescent protein (eGFP) or luciferase together with each polymerase component or NS1 of A/California/04/2009 (Cal) and found that PA has a significant impact on the expression of eGFP and luciferase. Comparison of the suppressive activity on coexpressed proteins between various strains revealed that avian virus or avian-origin PAs have much stronger activity than human-origin PAs, such as the one from A/WSN/33 (WSN). Protein synthesis data suggested that reduced expression of coexpressed proteins is not due to PA's reported proteolytic activity. A recombinant WSN containing Cal PA showed enhanced host protein synthesis shutoff and induction of apoptosis. Further characterization of the PA fragment indicated that the N-terminal domain (PANt), which includes the endonuclease active site, is sufficient to suppress cotransfected gene expression. By characterizing various chimeric PANts, we found that multiple regions of PA, mainly the helix α4 and the flexible loop of amino acids 51 to 74, affect the activity. The suppressive effect of PANt cDNA was mainly due to PA-X, which was expressed by ribosomal frameshifting. In both Cal and WSN viruses, PA-X showed a stronger effect than the corresponding PANt, suggesting that the unique C-terminal sequences of PA-X also play a role in suppressing cotransfected gene expression. Our data indicate strain variations in PA gene products, which play a major role in suppression of host protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23283952      PMCID: PMC3592176          DOI: 10.1128/JVI.02826-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Threonine 157 of influenza virus PA polymerase subunit modulates RNA replication in infectious viruses.

Authors:  Maite Huarte; Ana Falcón; Yuri Nakaya; Juan Ortín; Adolfo García-Sastre; Amelia Nieto
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 3.  Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.

Authors:  Robert M Krug; Weiming Yuan; Diana L Noah; Anita Ghate Latham
Journal:  Virology       Date:  2003-05-10       Impact factor: 3.616

4.  Cellular mRNA translation is blocked at both initiation and elongation after infection by influenza virus or adenovirus.

Authors:  M G Katze; D DeCorato; R M Krug
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis.

Authors:  Mirella Salvatore; Christopher F Basler; Jean-Patrick Parisien; Curt M Horvath; Svetlana Bourmakina; Hongyong Zheng; Thomas Muster; Peter Palese; Adolfo García-Sastre
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events.

Authors:  G K Geiss; M C An; R E Bumgarner; E Hammersmark; D Cunningham; M G Katze
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs.

Authors:  M G Katze; B M Detjen; B Safer; R M Krug
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

8.  A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription.

Authors:  S J Plotch; M Bouloy; I Ulmanen; R M Krug
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

9.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses.

Authors:  Sang Heui Seo; Erich Hoffmann; Robert G Webster
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

10.  An overlapping protein-coding region in influenza A virus segment 3 modulates the host response.

Authors:  B W Jagger; H M Wise; J C Kash; K-A Walters; N M Wills; Y-L Xiao; R L Dunfee; L M Schwartzman; A Ozinsky; G L Bell; R M Dalton; A Lo; S Efstathiou; J F Atkins; A E Firth; J K Taubenberger; P Digard
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

View more
  52 in total

Review 1.  Timing Is Everything: Coordinated Control of Host Shutoff by Influenza A Virus NS1 and PA-X Proteins.

Authors:  Denys A Khaperskyy; Craig McCormick
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

2.  Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses.

Authors:  Jinhwa Lee; Hai Yu; Yonghai Li; Jingjiao Ma; Yuekun Lang; Michael Duff; Jamie Henningson; Qinfang Liu; Yuhao Li; Abdou Nagy; Bhupinder Bawa; Zejun Li; Guangzhi Tong; Juergen A Richt; Wenjun Ma
Journal:  Virology       Date:  2017-01-29       Impact factor: 3.616

3.  An R195K Mutation in the PA-X Protein Increases the Virulence and Transmission of Influenza A Virus in Mammalian Hosts.

Authors:  Yipeng Sun; Zhe Hu; Xuxiao Zhang; Mingyue Chen; Zhen Wang; Guanlong Xu; Yuhai Bi; Qi Tong; Mingyang Wang; Honglei Sun; Juan Pu; Munir Iqbal; Jinhua Liu
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

4.  Mapping of a Region of the PA-X Protein of Influenza A Virus That Is Important for Its Shutoff Activity.

Authors:  Kohei Oishi; Seiya Yamayoshi; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 mice.

Authors:  Brittany L DesRochers; Rita E Chen; Anshu P Gounder; Amelia K Pinto; Traci Bricker; Camille N Linton; Corianne D Rogers; Graham D Williams; Richard J Webby; Adrianus C M Boon
Journal:  Virology       Date:  2016-04-20       Impact factor: 3.616

6.  PA-X decreases the pathogenicity of highly pathogenic H5N1 influenza A virus in avian species by inhibiting virus replication and host response.

Authors:  Jiao Hu; Yiqun Mo; Xiaoquan Wang; Min Gu; Zenglei Hu; Lei Zhong; Qiwen Wu; Xiaoli Hao; Shunlin Hu; Wenbo Liu; Huimou Liu; Xiaowen Liu; Xiufan Liu
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

Review 7.  Crucial role of PA in virus life cycle and host adaptation of influenza A virus.

Authors:  Jiao Hu; Xiufan Liu
Journal:  Med Microbiol Immunol       Date:  2014-07-29       Impact factor: 3.402

8.  Influenza A Virus Protein PA-X Contributes to Viral Growth and Suppression of the Host Antiviral and Immune Responses.

Authors:  Tsuyoshi Hayashi; Leslie A MacDonald; Toru Takimoto
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

9.  The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA.

Authors:  Laura Bavagnoli; Stefano Cucuzza; Giulia Campanini; Francesca Rovida; Stefania Paolucci; Fausto Baldanti; Giovanni Maga
Journal:  Nucleic Acids Res       Date:  2015-09-17       Impact factor: 16.971

10.  Truncation of PA-X Contributes to Virulence and Transmission of H3N8 and H3N2 Canine Influenza Viruses in Dogs.

Authors:  Litao Liu; Shikai Song; Ye Shen; Chao Ma; Tong Wang; Qi Tong; Honglei Sun; Juan Pu; Munir Iqbal; Jinhua Liu; Yipeng Sun
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.